CD8A and non-small cell lung carcinoma: We previously have reported that higher Treg/CD8+ ratio in tumor was an independent factor for poor response to platinum-based chemotherapy, but CD8+ and Treg tumor infiltrating lymphocytes was not correlated with any clinicopathological features in advanced NSCLC patients (37).